Project Details
| Short title | panSOHO |
|---|---|
| Status | Active |
| Effective start/end date | 10/12/24 → 31/10/29 |
CTU: A Phase 2 open-label basket study to evaluate the efficacy and safety of orally administered reversible tyrosine kinase inhibitor BAY 2927088 in participants with metastatic or unresectable solid tumors with HER2-activating mutations
- Zhang, Alison (Primary Chief Investigator)
- Chapman, Nicola (Clinical Trial Unit Staff)
- Quinlan, Gabriel (Clinical Trial Unit Staff)
- TAIDI, Gina (Clinical Trial Unit Staff)
- Martin, Lewis (Clinical Trial Unit Staff)
- Armstrong, Emilia (Clinical Trial Unit Staff)
- Garcia, Michelle (Clinical Trial Unit Staff)
Project: Research